Commonwealth Equity Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Commonwealth Equity Services’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-250	Closed	-$9K	–	3143
2020 Q2	$9K	Hold	250	–	–	﹤0.01%	2938
2020 Q1	$6K	Hold	250	–	–	﹤0.01%	2803
2019 Q4	$12K	Buy	+250	New	+$12.1K	﹤0.01%	2865
2018 Q3	–	Sell	-164	Closed	-$37K	–	2877
2018 Q2	$37K	Buy	+164	New	+$43.9K	﹤0.01%	2683

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Commonwealth Equity Services's DMK Position: Q3 2020 in Review

Commonwealth Equity Services sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2020, closing a stake of 250 shares — an estimated $9K sold.

Commonwealth Equity Services first reported a position in DMK in Q2 2018 and held it in 4 quarters. The position peaked at $37K in Q2 2018. 46 funds tracked by Wall St. Rank hold DMK as of Q3 2020.

Commonwealth Equity Services reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2020 after selling out during the quarter.
Commonwealth Equity Services sold 250 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2020, an estimated $9K.
Commonwealth Equity Services first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2018 and held it in 4 quarters.
Commonwealth Equity Services's DMK Pharmaceuticals Corporation Common Stock position peaked at $37K in Q2 2018.
46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2020.

Based on Commonwealth Equity Services's 13F filing for Q3 2020, filed 5 Nov 2020.